Kestra Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Kestra Advisory Services's DGX Position: Q3 2026 in Review
Kestra Advisory Services increased its Quest Diagnostics (DGX) stake by 4.4% in Q3 2026, buying an estimated $183K and bringing the position to 18,820 shares worth $4.39M. The position accounts for 0.01% of the portfolio, ranked #973.
Kestra Advisory Services first reported a position in DGX in Q3 2020 and has held it in 25 quarters since. 566 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Kestra Advisory Services held 18,820 shares of Quest Diagnostics worth $4.39M as of Q3 2026.
- Kestra Advisory Services bought 793 Quest Diagnostics shares in Q3 2026, an estimated $183K.
- Quest Diagnostics made up 0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #973 holding.
- Kestra Advisory Services first reported a position in Quest Diagnostics in Q3 2020 and has held it in 25 quarters since.
- 566 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.